1-9 of 9
Lori Hazlehurst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Stearoyl-CoA Desaturase Has Anti-Leukemic Properties in Acute Myeloid Leukemia

Vilma Dembitz, Hannah Lawson, Celine Philippe, Richard J. Burt, Sophie James, Aoife S.M. Magee, Keith Woodley, Jozef Durko, Joana Campos, Michael James Austin, Ana Rio-Machin, Pedro Casado Izquierdo, Findlay Bewicke-Copley, Giovanny Rodriguez Blanco, Bela Patel, Lori Hazlehurst, Barrie Peck, Andrew Finch, Pedro Cutillas, Jude Fitzgibbon, Mariia Yuneva, Kevin Rouault-Pierre, John Copland, III, Kamil Kranc, Paolo Gallipoli
Journal: Blood
Blood (2022) 140 (Supplement 1): 3058–3060.
https://doi.org/10.1182/blood-2022-166811
Published: 2022
Journal Articles

A Phase I Study of Ruxolitinib Plus Nilotinib in Chronic Phase CML Patients with Molecular Evidence of Disease

Kendra L. Sweet, MD, Lori Hazlehurst, PhD, Eva Sahakian, PhD, John J. Powers, B.S., Lisa Nodzon, PhD ANP, Fadi Kayali, MD, Kelly Hyland, Ashley Nelson, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1892.
https://doi.org/10.1182/blood.V128.22.1892.1892
Published: 2016
Journal Articles

Targeting PYK2 Mediates Microenvironment-Specific Myeloma Cell Death

Kenneth H. Shain, MD PhD, Mark B Meads, PhD, Bin Fang, PhD, Linda Mathews, Jennifer Gemmer, Liang Nong, MD, Ismael Rosado-Lopez, BS, Jennifer E. Ring, Robert MacLeod, PhD, Lori Hazlehurst, PhD, Conor Lynch, PhD, Jonathan A. Pachter, PhD, William Matsui, MD, John Koomen, PhD, Tuan Nguyen
Journal: Blood
Blood (2014) 124 (21): 2081.
https://doi.org/10.1182/blood.V124.21.2081.2081
Published: 2014
Journal Articles

Influence of Targeted Therapy in Redefining High-Risk Myeloma.

Lori Hazlehurst, PhD, William S. Dalton, MD, PhD, Danielle Yarde, Yulia Nefedova, MD, PhD, Dmitry Gabrilovich
Journal: Blood
Blood (2008) 112 (11): sci-7.
https://doi.org/10.1182/blood.V112.11.sci-7.sci-7
Published: 2008
Journal Articles

β1 Integrin Adhesion Enhances IL-6 Mediated STAT3 Signaling in Multiple Myeloma Cells: Implications for Microenvironment Influence on Tumor Cell Survival and Proliferation.

Kenneth H Shain, M.D., Ph.D., Danielle Yarde, Mark Mead, Ph.D., Lori Hazlehurst, Ph.D., William S Dalton, M.D., Ph.D
Journal: Blood
Blood (2008) 112 (11): 1706.
https://doi.org/10.1182/blood.V112.11.1706.1706
Published: 2008
Journal Articles

ABCG2 expression, function, and promoter methylation in human multiple myeloma

Joel G. Turner, Jana L. Gump, Chunchun Zhang, James M. Cook, Douglas Marchion, Lori Hazlehurst, Pamela Munster, Michael J. Schell, William S. Dalton, Daniel M. Sullivan
Journal: Blood
Blood (2006) 108 (12): 3881–3889.
https://doi.org/10.1182/blood-2005-10-009084
Published: 2006
Journal Articles

Bortezomib-Induced Reversal of CAM-DR Phenotype in Myeloma Is Associated with AKT and ERK1/2 Signaling.

Ramadevi Nimmanapalli, Ph.D, Lori Hazlehurst, Ph.D, Steven Enkemann, Ph.D, Melissa Alsina, M.D., William S. Dalton, M.D., Ph.D
Journal: Blood
Blood (2004) 104 (11): 3357.
https://doi.org/10.1182/blood.V104.11.3357.3357
Published: 2004
Journal Articles

Influence of Fibronectin,(FN), Adhesion on Gene Expression Profiles, (GEP), of Isolated Patient Myeloma Cells.

Melissa Alsina, MD, Ramadevi Nimmanapalli, PhD, Mackley A. Paul, Gerbino Elvira, Lori Hazlehurst, Ph.D, Steven Enkemann, PhD, Beam Craig, PhD, William S. Dalton, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2345.
https://doi.org/10.1182/blood.V104.11.2345.2345
Published: 2004
Journal Articles

Enhanced DNA Repair Via Fanconi Anemia/BRCA Pathway Is Involved in Melphalan-Resistant Myeloma Cells.

Qing Chen, Ph.D, Pieter C. Van der Sluis, BSc, Lori Hazlehurst, Ph.D, William S. Dalton, Ph.D, MD.
Journal: Blood
Blood (2004) 104 (11): 284.
https://doi.org/10.1182/blood.V104.11.284.284
Published: 2004